Saakshi Medtech and Panels Limited — Important, 07-08-2026: Disclosure of material issue

Saakshi Medtech (@SAAKSHI) has received in-principle approval from NSE for a preferential issue of 20,22,940 equity shares.

* **Issue:** This approval is a key step for Saakshi Medtech to complete a share swap transaction to acquire Laxmi Engineering Industries Bhopal Pvt Ltd. The shares, valued at Rs 207 per equity share, will be allotted to promoters, bringing the total value of this issuance to approximately Rs 41.87 Cr.

* **Impact:** This move enables a strategic acquisition, signaling a growth path for the company. While it involves the issuance of new shares, it's a way to fund expansion through a share swap rather than cash. For existing shareholders, it implies a potential dilution in ownership if they do not participate, but the acquisition could create long-term value.

* **Company’s Response/Mitigation:** The company is now cleared to proceed with the preferential issue. It must fulfill several conditions, including filing the listing application promptly, obtaining other necessary statutory approvals, and strengthening internal controls to monitor trading by the allottees. The NSE approval is valid for 15 days, emphasizing the timeline for the company to act. #SAAKSHI #EquityNews